nivolumab,COM-701
bms
['nivolumab', 'nivo']
combining nivolumab with a novel checkpoint inhibitor targeting pvrig demonstrates early antitumor activity in microsatellite-stable colorectal cancer. our dr. michael overman presents abstract 659 at #sitc22: #endcancer 